In Biden administration’s final days, FDA advances proposal to set a nicotine limit on tobacco products
As the Biden administration winds down, the US Food and Drug Administration has submitted a proposed rule that could ...
FDA asks Biden administration to reduce nicotine content in tobacco products
The U.S. Food and Drug Administration has proposed a rule that would significantly lower the amount of nicotine in tobacco ...
F.D.A. Tries Last-Ditch Move to Slash Nicotine Levels in Cigarettes
The agency is asking the White House, in the final days of the Biden era, to move ahead with plans to drastically reduce the ...
Rutgers University5d
Why the FDA Should Move Fast to Regulate Nicotine Pouches
In a commentary published in JAMA, experts at the Rutgers Institute for Nicotine & Tobacco Studies have issued a call to ...
Weight loss drugs may also treat addiction, Alzheimer’s, and heart disease
But weight loss alone does not explain the drugs’ benefits. Both Holst and Sattar pointed to a discontinued GLP-1 drug once ...
22nd Century Applauds FDA Proposal to Mandate Reduced Nicotine Content in Cigarettes
Recent FDA Action Advances Policy Proposal That Originated During First Trump Administration and Continued to Progress Under Biden ...
STAT4d
Eli Lilly to test obesity medications as treatments for alcohol and drug addiction, CEO says
Eli Lilly will start studying its obesity products as treatments for alcohol and drug abuse, making it the first major ...
Zyn, vapes, and the wild rebranding of nicotine
Vapes blew open the market, leading to a new era of experimentation—and a chance for brands to cash in. Buffalo Bills ...
R Street Institute3d
R Street Testimony in Opposition of the Needham Board of Health Regulations Restricting the Sale of Reduced Risk Nicotine Products
Jeffrey S. Smith, Senior Fellow, Integrated Harm Reduction, R Street Institute R Street Testimony in Opposition of the Needham Board of Health Regulations Restricting the Sale of Reduced Risk Nicotine ...
FDA seeks White House approval to cut nicotine levels in cigarettes, NYT says
The Food and Drug Administration is seeking approval from the Biden administration in its fifnal months to propose a major reduction in the ...
Qnovia, Inc. Raises $16 Million in Series B Financing to Advance Lead Asset RespiRx™ Nicotine Inhaler as a Prescription Smoking Cessation Therapy
Qnovia, Inc., a pharmaceutical company who recently announced the clearance of its Investigational New Drug (IND) application by the U.S. Food and Drug Administration (FDA) for the RespiRx™ Nicotine ...